258 related articles for article (PubMed ID: 9747878)
1. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
2. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; PĂ©rez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
[TBL] [Abstract][Full Text] [Related]
5. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB.
Murga C; Zohar M; Teramoto H; Gutkind JS
Oncogene; 2002 Jan; 21(2):207-16. PubMed ID: 11803464
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
7. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
[TBL] [Abstract][Full Text] [Related]
8. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
9. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
[TBL] [Abstract][Full Text] [Related]
10. A mutant form of the rho protein can restore stress fibers and adhesion plaques in v-src transformed fibroblasts.
Mayer T; Meyer M; Janning A; Schiedel AC; Barnekow A
Oncogene; 1999 Mar; 18(12):2117-28. PubMed ID: 10321736
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution.
Kimmelman A; Tolkacheva T; Lorenzi MV; Osada M; Chan AM
Oncogene; 1997 Nov; 15(22):2675-85. PubMed ID: 9400994
[TBL] [Abstract][Full Text] [Related]
12. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.
Westwick JK; Lambert QT; Clark GJ; Symons M; Van Aelst L; Pestell RG; Der CJ
Mol Cell Biol; 1997 Mar; 17(3):1324-35. PubMed ID: 9032259
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic function of Rac in hematopoietic cells.
Nishida K; Kaziro Y; Satoh T
Oncogene; 1999 Jan; 18(2):407-15. PubMed ID: 9927197
[TBL] [Abstract][Full Text] [Related]
14. Rho small G protein and cytoskeletal control.
Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
[TBL] [Abstract][Full Text] [Related]
15. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
Sahai E; Alberts AS; Treisman R
EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
[TBL] [Abstract][Full Text] [Related]
16. Different structural organization of Ras and Rho effector domains.
Self AJ; Paterson HF; Hall A
Oncogene; 1993 Mar; 8(3):655-61. PubMed ID: 8437849
[TBL] [Abstract][Full Text] [Related]
17. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
18. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
Zong H; Kaibuchi K; Quilliam LA
Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
20. An essential role for Rac in Ras transformation.
Qiu RG; Chen J; Kirn D; McCormick F; Symons M
Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]